These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9730430

  • 1. Mixed allogeneic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplant model.
    Gammie JS, Li S, Kawaharada N, Colson YL, Yousem S, Ildstad ST, Pham SM.
    J Heart Lung Transplant; 1998 Aug; 17(8):801-8. PubMed ID: 9730430
    [Abstract] [Full Text] [Related]

  • 2. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL, Zadach K, Nalesnik M, Ildstad ST.
    Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 4. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
    Gorantla VS, Prabhune KA, Perez-Abadia G, Ildstad ST, Maldonado C, Orhun HI, Majzoub RK, Francois CG, Kakoulidis TP, Brouha PC, Anderson GL, Pidwell DJ, Breidenbach WC, Barker JH.
    Transplantation; 2003 Apr 15; 75(7):922-32. PubMed ID: 12698075
    [Abstract] [Full Text] [Related]

  • 5. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 6. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD, Pham S, Li S, Aitouche A.
    Transplantation; 2003 Sep 27; 76(6):988-94. PubMed ID: 14508367
    [Abstract] [Full Text] [Related]

  • 7. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS, Li S, Colson YL, Demetris AJ, Neipp M, Ildstad ST, Pham SM.
    Exp Hematol; 1998 Sep 27; 26(10):927-35. PubMed ID: 9728927
    [Abstract] [Full Text] [Related]

  • 8. Induction of specific tolerance to small-bowel allografts.
    Orloff MS, Fallon MA, DeMara E, Coppage ML, Leong N, Cerilli J.
    Surgery; 1994 Aug 27; 116(2):222-8. PubMed ID: 8047988
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
    Fernández FG, McKane B, Marshbank S, Patterson GA, Mohanakumar T.
    J Heart Lung Transplant; 2005 Jul 27; 24(7 Suppl):S232-8. PubMed ID: 15993779
    [Abstract] [Full Text] [Related]

  • 10. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ.
    Transplantation; 2001 Sep 15; 72(5):791-7. PubMed ID: 11571439
    [Abstract] [Full Text] [Related]

  • 11. Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts.
    Li H, Abou el-Ezz AY, Gambrell BE, Ildstad ST.
    Transplantation; 1995 Jul 15; 60(1):59-65. PubMed ID: 7624944
    [Abstract] [Full Text] [Related]

  • 12. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY, Krasinskas AM, Kreisel D, Popma SH, Rosengard BR.
    J Thorac Cardiovasc Surg; 2000 Dec 15; 120(6):1070-7. PubMed ID: 11088028
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J, Ko S, Kanehiro H, Kanokogi H, Nakajima Y.
    J Surg Res; 2006 Jun 15; 133(2):61-8. PubMed ID: 16376943
    [Abstract] [Full Text] [Related]

  • 14. Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.
    van Pel M, Hilbrands L, Smits D, van Breugel DW, van Eck M, Boog CJ.
    Transpl Immunol; 2003 Jun 15; 11(1):57-63. PubMed ID: 12727476
    [Abstract] [Full Text] [Related]

  • 15. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z, Yang DY, Wang R, Wang SZ, Ping YM.
    Zhonghua Wai Ke Za Zhi; 2007 Feb 15; 45(4):262-6. PubMed ID: 17502025
    [Abstract] [Full Text] [Related]

  • 16. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
    Deuse T, Schrepfer S, Reichenspurner H, Hoyt G, Fischbein MP, Robbins RC, Pelletier MP.
    Transpl Immunol; 2007 Jun 15; 17(4):255-61. PubMed ID: 17493528
    [Abstract] [Full Text] [Related]

  • 17. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.
    Orloff MS, DeMara EM, Coppage ML, Leong N, Fallon MA, Sickel J, Zuo XJ, Prehn J, Jordan SC.
    Transplantation; 1995 Jan 27; 59(2):282-8. PubMed ID: 7839452
    [Abstract] [Full Text] [Related]

  • 18. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 19. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.
    Li H, Ricordi C, Demetris AJ, Kaufman CL, Korbanic C, Hronakes ML, Ildstad ST.
    Transplantation; 1994 Feb 27; 57(4):592-8. PubMed ID: 8116047
    [Abstract] [Full Text] [Related]

  • 20. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
    Suemitsu R, Yoshino I, Shoji F, Yamaguchi M, Tomita Y, Maehara Y.
    J Surg Res; 2004 Nov 27; 122(1):8-13. PubMed ID: 15522308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.